Retatrutide, a novel dual stimulator of the GLP-1 target and glucose-dependent secreted polypeptide (GIP) binding site , is showing promising results in preliminary human assessments . Ongoing https://shopretatrutidepeptide.com/retatrutide-research-knowledge-hub/